• linkedin
  • Increase Font
  • Sharebar

    New Products: FDA approves treatment for complicated UTI



    Sirius MRI Marker



    Additional 510(k) clearance granted for prostate MRI Marker

    The FDA has granted an additional 510(k) clearance for the Sirius MRI Marker, a novel positive-signal MRI Marker that is used during the treatment of prostate cancer with brachytherapy. This additional 510(k) clears Sirius MRI Markers to be sterilized with ethylene oxide; previously, only gamma sterilization was available, according to manufacturer C4 Imaging LLC. The addition of ethylene oxide as an option increases convenience for customers and allows the benefits of MRI-assisted brachytherapy with Sirius to be made available to more prostate cancer patients, the company says.

    For more information, go to www.c4imaging.com/.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available